2014
DOI: 10.1590/s1415-47572014000200018
|View full text |Cite
|
Sign up to set email alerts
|

A tribute to José María ("Chema") Cantú

Abstract: José María (“Chema”) Cantú (1938–2007), born in Mexico, was a pioneering, loved and respected leader in medical and human genetics and bioethics in Latin America. He graduated as a physician in Mexico and then trained in medical and human genetics in France and the United States. He was instrumental in developing a first-rate research, training and genetic services program in medical and human genetics in Guadalajara, in northwestern Mexico. He acted forcefully at national, regional and international levels to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…The first symposium, 'Pharmacogenetics of indigenous and mestizo populations and its clinical implications' was chaired by Ronald Ramírez Roa (UNAN-Leon, Nicaragua). The first talk was given by Enrique Teran (USFQ, Ecuador) who presented a historical overview of the Ibero-American Program for Science, Technology and Development (CYTED), and how the late Mexican geneticist Jose María 'Chema' Cantú and a Spanish clinical pharmacologist, Adrián LLerena were the keystone for the Iberoamerican Network on Pharmacogenetics [6].…”
mentioning
confidence: 99%
“…The first symposium, 'Pharmacogenetics of indigenous and mestizo populations and its clinical implications' was chaired by Ronald Ramírez Roa (UNAN-Leon, Nicaragua). The first talk was given by Enrique Teran (USFQ, Ecuador) who presented a historical overview of the Ibero-American Program for Science, Technology and Development (CYTED), and how the late Mexican geneticist Jose María 'Chema' Cantú and a Spanish clinical pharmacologist, Adrián LLerena were the keystone for the Iberoamerican Network on Pharmacogenetics [6].…”
mentioning
confidence: 99%